113 related articles for article (PubMed ID: 21781664)
1. Selective drug efflux in multidrug-resistant immunoblastic B lymphoma cells with overexpressed P-glycoprotein.
Chao CC
Environ Toxicol Pharmacol; 1996 Feb; 1(1):63-72. PubMed ID: 21781664
[TBL] [Abstract][Full Text] [Related]
2. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
Chao CC
FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
[TBL] [Abstract][Full Text] [Related]
3. Cross-resistance to cis-diamminedichloroplatinum(II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair.
Chao CC
Eur J Pharmacol; 1996 Jun; 305(1-3):213-22. PubMed ID: 8813556
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistant HOB1 lymphoma cells express P-glycoprotein that does not play the major role in the development of drug resistance to adriamycin.
Lee WP; Lee CL; Kao MC
Biochem Biophys Res Commun; 1992 Nov; 189(1):92-100. PubMed ID: 1360209
[TBL] [Abstract][Full Text] [Related]
5. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells.
Chiang CD; Song EJ; Yang VC; Chao CC
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):759-64. PubMed ID: 7914401
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferase and glutathione peroxidase are essential in the early stage of adriamycin resistance before P-glycoprotein overexpression in HOB1 lymphoma cells.
Lee WP; Lee CL; Lin HC
Cancer Chemother Pharmacol; 1996; 38(1):45-51. PubMed ID: 8603451
[TBL] [Abstract][Full Text] [Related]
7. L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines.
Chiu LY; Ko JL; Lee YJ; Yang TY; Tee YT; Sheu GT
Toxicol Lett; 2010 Feb; 192(3):408-18. PubMed ID: 19944135
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
[TBL] [Abstract][Full Text] [Related]
9. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
[TBL] [Abstract][Full Text] [Related]
10. Involvement of reactive oxygen species in multidrug resistance of a vincristine-selected lymphoblastoma.
Tsai SY; Sun NK; Lu HP; Cheng ML; Chao CC
Cancer Sci; 2007 Aug; 98(8):1206-14. PubMed ID: 17517054
[TBL] [Abstract][Full Text] [Related]
11. Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression.
Slapak CA; Daniel JC; Levy SB
Cancer Res; 1990 Dec; 50(24):7895-901. PubMed ID: 1979251
[TBL] [Abstract][Full Text] [Related]
12. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems.
Cleary I; Doherty G; Moran E; Clynes M
Biochem Pharmacol; 1997 May; 53(10):1493-502. PubMed ID: 9260877
[TBL] [Abstract][Full Text] [Related]
13. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
[TBL] [Abstract][Full Text] [Related]
14. Non-P-glycoprotein-mediated multidrug-resistant human KB cells selected in medium containing adriamycin, cepharanthine, and mezerein.
Sumizawa T; Chuman Y; Sakamoto H; Iemura K; Almquist KC; Deeley RG; Cole SP; Akiyama S
Somat Cell Mol Genet; 1994 Sep; 20(5):423-35. PubMed ID: 7825064
[TBL] [Abstract][Full Text] [Related]
15. Characterization of vincristine-resistant HOB1 lymphoma cell line showing the classical MDR phenotype and altered expression of membrane glycoproteins.
Lee WP; Lee CL
Oncology; 1994; 51(1):2-8. PubMed ID: 7903440
[TBL] [Abstract][Full Text] [Related]
16. Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein.
Liu Z; Zhu H; Qu S; Tang L; Cao L; Yu W; Yang X; Jiang S; Zhu D; Tan C; Yu L
Anticancer Agents Med Chem; 2018; 18(2):286-294. PubMed ID: 28782465
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of adriamycin-resistant human colorectal adenocarcinoma HCT-15 cell lines with multidrug resistance.
Uchiyama-Kokubu N; Watanabe T
Anticancer Drugs; 2001 Oct; 12(9):769-79. PubMed ID: 11593059
[TBL] [Abstract][Full Text] [Related]
18. Tunicamycin potentiates drug cytotoxicity and vincristine retention in multidrug resistant cell lines.
Hiss D; Gabriels G; Jacobs P; Folb P
Eur J Cancer; 1996 Nov; 32A(12):2164-72. PubMed ID: 9014761
[TBL] [Abstract][Full Text] [Related]
19. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
Politi PM; Sinha BK
Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628
[TBL] [Abstract][Full Text] [Related]
20. [Vincristine-resistant human KB cell line and mechanism of multidrug resistance].
Zhang XH; Zhang FY; Ji XJ; Li ZY
Yao Xue Xue Bao; 1994; 29(4):246-51. PubMed ID: 7976338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
